Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)
Massachusetts Institute of Technology · NCT07496918
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 150
- US sites recruiting
- 1
- Study start
- February 20, 2018
- Record last updated
- March 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Despite the huge healthcare and economic impact of AD, there is still no disease modifying therapeutics available. In fact, the available therapeutics show low efficacy at best in the treatment of cognitive impairment in dementia. Development of a non-invasive medical device that is effective in slowing cognitive impairment is not only revolutionary but also possibly cost- effective. In this study, participants will come to MIT for a 1-day visit and the investigators will evaluate the effects of GENUS in cognitively normal, healthy adults. Investigators will use Electroencephalogram (EEG), Magnetoencephalography (MEG), magnetic resonance imaging (MRI), neuropsychological testing, and blood sampling in subsets of participants to evaluate for biological effects and safety of GENUS stimulation.
Being studied: GENUS; Tactile GENUS
Conditions: Cognitively Healthy People; Alzheimer Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Have adequate visual and auditory acuity for visual and auditory stimulation to allow for neuropsychological testing.
- Be able to comply with neuropsychological testing and other study procedures in opinion of site PI.
Exclusion Criteria: Participants will be screened for the following exclusion criteria including if they
- History of seizure or medical diagnosis of epilepsy.
- Have MRI contraindications, such as presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments, or foreign objects in the eyes, skin, or body.
- Under the discretion of the site investigator, the site investigator feels the subject cannot complete sufficient key study procedures. Exceptions to these guidelines may be considered on a case-by-case basis at the discretion of the Project Director.
Recruiting US locations
MIT
Cambridge, MA 02139
Site contact: Ana Trisini Lipsanopoulos, BS · 617-258-7723 · anat13@mit.edu
Study contacts (from the official record)
- gamma wave · 617-258-7723 · gamma.wave@mit.edu
- Ana Trisini Lipsanopoulos, BS · 617-258-7723 · anat13@mit.edu
Similar studies in Massachusetts
All neurology studies in Massachusetts →- RecruitingHealthy volunteersPhase 1
Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation
General Biophysics LLC
- Location
- Boston, MA
- Eligibility basics
- Ages 55–75
- RecruitingPhase 1/Phase 2Overnight stay mentioned
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Vector Y Therapeutics
- Location
- Boston, MA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
Massachusetts General Hospital
- Location
- Boston, MA
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
Massachusetts General Hospital
- Location
- Boston, MA
- Eligibility basics
- Ages 40–99